Version 9 of Flare, Cresset’s CADD solution, brings new and enhanced scientific features and methods for all users. These include Homology Modeling to create reliable 3D models for protein targets for which crystallographic information is not available, ensemble Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) on dynamics trajectories for estimating binding free energy, a full integration […]

Key appointment brings extensive software commercial experience to drive global growth CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery and molecular design, today announced the appointment of James Halle as Chief Commercial Officer (CCO). James brings extensive software experience in the pharma industry and will guide the commercial success […]

Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa. — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leading provider of cheminformatics software. The transaction is expected to close in the […]

Mestrelab Research, a leading vendor-agnostic software provider for analytical chemistry data processing, has announced a partnership with ADG to further its commitment to its customers and resellers in the Chinese market. Mestrelab Research is an agile and experienced developer of advanced software solutions and tools for the pharmaceutical, chemical, and scientific research communities to enhance […]

Cresset is pleased to announce the successful completion of its SOC 2®  (System and Organization Controls 2) Type 1 audit, achieving compliance with the leading industry standards for customer data security. This demonstrates our ongoing commitment to providing a secure data environment for our customers. Developed by the American Institute of Certified Public Accountants (AICPA), a SOC […]

Partnership to facilitate collaborative research in academia and industry to further progress in life sciences. DARMSTADT, GERMANY Partnership to facilitate collaborative research in academia and industry to further progress in life sciences Multi-dimensional program to build local research capability and startup ecosystem as well as joint R&D projects Further example of Merck’s close cooperation with […]

Over 2.5 million users have downloaded ChemSketch Freeware, the academic chemical drawing software from ACD/Labs Toronto, CANADA — ACD/Labs, an informatics company that develops and commercializes software in support of digitalized R&D, today announced that ChemSketch Freeware has been downloaded by over 2.5 million users worldwide. This free version of ChemSketch, intended for academic and personal use, […]

— Next-generation suite enhances research productivity and innovation across chemical, pharmaceutical, and biotechnology industries and academia — Seamless integration within Revvity Signals Research platform empowers multidisciplinary discoveries WALTHAM, Mass. — Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software, is introducing the new Signals ChemDraw® offering, the latest advancement in the Revvity Signals Software portfolio. […]

Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the launch of Semeta™, a metabolism prediction platform tailored specifically for drug metabolism […]

Cambridge, UK – Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration with Enamine, the world’s leading provider of chemical building blocks and drug discovery services to develop innovative new solutions for the early drug discovery process. The newly announced collaboration involves the development of groundbreaking technology to enable the […]